Leveraging Metabolic-Driven Treatment Strategies to Target the Origins of NASH

In these unlocked downloadable slides, experts provide a review of therapeutic interventions for NAFLD/NASH including key recommendations from the latest clinical care guidelines and the safety and efficacy of emerging agents.
Manal F. Abdelmalek, MD, MPH
Program Director
Rohit Loomba, MD, MHSc
Brent Tetri, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 7.6 MB
Released: November 4, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Novo Nordisk Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings